Efficacy of anidulafungin in the treatment of experimentalCandida parapsilosiscatheter infection using an antifungal-lock technique

Mechanisms of echinocandin antifungal drug resistance

(2015) David S. Perlin   Annals of the New York Academy of Sciences

Micafungin at Physiological Serum Concentrations Shows Antifungal Activity against Candida albicans and Candida parapsilosis Biofilms

(2014) M. Guembe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*

(2014) Mireia Puig-Asensio et al.   CRITICAL CARE MEDICINE

Activities of Systemically Administered Echinocandins againstIn VivoMature Candida albicans Biofilms Developed in a Rat Subcutaneous Model

(2013) Soňa Kucharíková et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain

(2013) M. Puig-Asensio et al.   CLINICAL MICROBIOLOGY AND INFECTION

Antibiotic-lock therapy: a clinical viewpoint

(2013) Nuria Fernández-Hidalgo et al.   Expert Review of Anti-Infective Therapy

Management of infections related to totally implantable venous-access ports: challenges and perspectives

(2013) David Lebeaux et al.   LANCET INFECTIOUS DISEASES

Antifungal Lock Therapy

(2012) Carla J. Walraven et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Influence of material on the development of device-associated infections

(2012) E.T.J. Rochford et al.   CLINICAL MICROBIOLOGY AND INFECTION

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*

(2012) Maiken C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

The effect of biomaterials and antifungals on biofilm formation by Candida species: a review

(2012) M. Cuéllar-Cruz et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

In Vitro Activities of Anidulafungin and Other Antifungal Agents against Biofilms Formed by Clinical Isolates of Different Candida and Aspergillus Species

(2011) Barbara Fiori et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Could liposomal amphotericin B (L-AMB) lock solutions be useful to inhibit Candida spp. biofilms on silicone biomaterials?

(2011) D. Toulet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin-lock therapy

(2011) Halil Özdemir et al.   MYCOSES

Ethanol Locks Therapy for Resolution of Fungal Catheter Infections

(2011) Roland Alexander Blackwood et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Interaction of Candida albicans Biofilms with Antifungals: Transcriptional Response and Binding of Antifungals to Beta-Glucans

(2010) G. Vediyappan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biofilm production and evaluation of antifungal susceptibility amongst clinicalCandidaspp. isolates, including strains of theCandida parapsilosiscomplex

(2010) Analy S. Melo et al.   MEDICAL MYCOLOGY

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter‐Related Infection: 2009 Update by the Infectious Diseases Society of America

(2009) Leonard A. Mermel et al.   CLINICAL INFECTIOUS DISEASES

In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth

(2008) E. Cateau et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro growth and analysis of Candida biofilms

(2008) Jyotsna Chandra et al.   Nature Protocols